Varaico: Literature-Extracted Genetic Variants

Gene:FUS
Variant:p.R522G
Back to variants list

FUS

NM_004960.4:p.R522G

Associated Papers

Autophagy induction mitigates FUS aggregate formation and early synaptic dysfunction at the NMJ in the FUS-ALS model.

Malik T et al.

Biorxiv : the Preprint Server for Biology, 2026

The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation.

Koyuncu S et al.

Nature Aging, 2025

M6A-dependent RNA condensation underlies FUS autoregulation and can be harnessed for ALS therapy development.

Huang WP et al.

Science Advances, 2025

The Impact of Splicing Dysregulation on Neuromuscular Disorders and Current Neuromuscular Genetic Therapies.

Wu J et al.

Journal of Neurochemistry, 2025

Single-cell RNA-sequencing reveals early mitochondrial dysfunction unique to motor neurons shared across FUS- and TARDBP-ALS.

Schweingruber C et al.

Nature Communications, 2025

40389397 (PubMed )
Supplement: 41467_2025_59679_MOESM3_ESM.xlsx › FUS_Clinical_Data

Exploring Protein Misfolding in Amyotrophic Lateral Sclerosis: Structural and Functional Insights.

Ivantsik O et al.

Biomedicines, 2025

ALS-associated FUS mutation reshapes the RNA and protein composition of stress granules.

Mariani D et al.

Nucleic Acids Research, 2024

Decoding Missense Variants by Incorporating Phase Separation via Machine Learning.

Feng M et al.

Nature Communications, 2024

39333476 (PubMed )
Supplement: 41467_2024_52580_MOESM4_ESM.xlsx › impact_ps_mutations

The implications of physiological biomolecular condensates in amyotrophic lateral sclerosis.

Fakim H et al.

Seminars in Cell & Developmental Biology, 2024

Animal Models of FUS-Proteinopathy: A Systematic Review.

Rezvykh A et al.

Biochemistry. Biokhimiia, 2024

Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy.

Bagyinszky E et al.

Cells, 2023

Regulation of RNG105/caprin1 dynamics by pathogenic cytoplasmic FUS and TDP-43 in neuronal RNA granules modulates synaptic loss.

Horio T et al.

Heliyon, 2023

Generation of an Open-Access Patient-Derived iPSC Biobank for Amyotrophic Lateral Sclerosis Disease Modelling.

Hedges EC et al.

Genes, 2023

Caenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders.

Roussos A et al.

Biomolecules, 2023

Mutated FUS in familial amyotrophic lateral sclerosis involves multiple hnRNPs in the formation of neuronal cytoplasmic inclusions.

Honda H et al.

Journal of Neuropathology and Experimental Neurology, 2023

Potential roles of the endoplasmic reticulum stress pathway in amyotrophic lateral sclerosis.

Jeon YM et al.

Frontiers in Aging Neuroscience, 2023

Characterising the Genetic Landscape of Amyotrophic Lateral Sclerosis: A Catalogue and Assessment of Over 1,000 Published Genetic Variants.

McCann EP et al.

Journal of Neuromuscular Diseases, 2023

37638449 (PubMed )
Supplement: jnd-10-jnd230148-s001.xlsx › variant_list

Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders.

Naskar A et al.

Frontiers in Molecular Neuroscience, 2023

Simple models to understand complex disease: 10 years of progress from Caenorhabditis elegans models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Eck RJ et al.

Frontiers in Neuroscience, 2023

Proteostasis impairment and ALS.

Lambert-Smith IA et al.

Progress in Biophysics and Molecular Biology, 2022

FUS-P525L Juvenile Amyotrophic Lateral Sclerosis and Intellectual Disability: Evidence for Association and Oligogenic Inheritance.

Goldstein O et al.

Neurology. Genetics, 2022

The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

Davidson JM et al.

Neurobiology of Disease, 2022

Homozygous ALS-linked FUS P525L mutations cell- autonomously perturb transcriptome profile and chemoreceptor signaling in human iPSC microglia.

Kerk SY et al.

Stem Cell Reports, 2022

ALS-linked cytoplasmic FUS assemblies are compositionally different from physiological stress granules and sequester hnRNPA3, a novel modifier of FUS toxicity.

An H et al.

Neurobiology of Disease, 2022

The Role of VCP Mutations in the Spectrum of Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.

Scarian E et al.

Frontiers in Neurology, 2022

Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives.

Bonifacino T et al.

International Journal of Molecular Sciences, 2021

Targeted sequencing panels in Italian ALS patients support different etiologies in the ALS/FTD continuum.

Bartoletti-Stella A et al.

Journal of Neurology, 2021

33770234 (PubMed )
Supplement: 415_2021_10521_MOESM1_ESM.docx

Systemic regulation of mitochondria by germline proteostasis prevents protein aggregation in the soma of C. elegans.

Calculli G et al.

Science Advances, 2021

Generation of six induced pluripotent stem cell lines from patients with amyotrophic lateral sclerosis with associated genetic mutations in either FUS or ANXA11.

Hedges EC et al.

Stem Cell Research, 2021

Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster.

Layalle S et al.

International Journal of Molecular Sciences, 2021

Stress granule subtypes: an emerging link to neurodegeneration.

Advani VM et al.

Cellular and Molecular Life Sciences : Cmls, 2020

A de novo c.1509dupA:p.R503fs mutation of FUS: report of a girl with sporadic juvenile amyotrophic lateral sclerosis.

Chen L et al.

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2020

The Occurrence of FUS Mutations in Pediatric Amyotrophic Lateral Sclerosis: A Case Report and Review of the Literature.

Picher-Martel V et al.

Journal of Child Neurology, 2020

Cytoplasmic functions of TDP-43 and FUS and their role in ALS.

Birsa N et al.

Seminars in Cell & Developmental Biology, 2020

Antiviral Immune Response as a Trigger of FUS Proteinopathy in Amyotrophic Lateral Sclerosis.

Shelkovnikova TA et al.

Cell Reports, 2019

Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization.

Casci I et al.

Nature Communications, 2019

Cellular consequences of arginine methylation.

Lorton BM et al.

Cellular and Molecular Life Sciences : Cmls, 2019

Disrupted neuronal trafficking in amyotrophic lateral sclerosis.

Burk K et al.

Acta Neuropathologica, 2019

Fused in Sarcoma: Properties, Self-Assembly and Correlation with Neurodegenerative Diseases.

Chen C et al.

Molecules (basel, Switzerland), 2019

The role of de novo mutations in adult-onset neurodegenerative disorders.

Nicolas G et al.

Acta Neuropathologica, 2019

30478624 (PubMed )
Supplement: 401_2018_1939_MOESM1_ESM.xlsx › Supp_Table_2_FTLD_spectrum

RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.

Hofmann JW et al.

Annual Review of Pathology, 2019

ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles.

An H et al.

Acta Neuropathologica Communications, 2019

30642400 (PubMed )
Supplement: 40478_2019_658_MOESM1_ESM.docx
1–50 of 114 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."